Trupanion (NASDAQ:TRUP) Stock: Insider Margaret Tooth Sells 1,000 Shares

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 1,000 shares of the firm’s stock in a transaction dated Friday, October 9th. The stock was sold at an average price of $25.84, for a total transaction of $25,840.00. Following the completion of the sale, the chief executive officer owned 184,952 shares of the company’s stock, valued at $4,779,159.68. This trade represents a 0.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Margaret Tooth also recently made the following trade(s):

• On Friday, September 11th, Margaret Tooth sold 1,000 shares of Trupanion stock. The shares were sold at an average price of $25.00, for a total value of $25,000.00.
• On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The stock was sold at an average price of $31.84, for a total value of $15,633.44.
• On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The stock was sold at an average price of $29.05, for a total value of $28,410.90.

Trupanion Stock Up 0.6%

Shares of NASDAQ:TRUP opened at $26.73 on Thursday. The firm has a market capitalization of $1.17 billion, a P/E ratio of 50.13, a P/E/G ratio of 1.59 and a beta of 1.44. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a 50 day moving average price of $27.04 and a 200-day moving average price of $25.52. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $46.98.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. The company had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. Trupanion had a return on equity of 5.96% and a net margin of 1.53%. The firm’s revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.22 earnings per share. As a group, equities research analysts anticipate that Trupanion, Inc. will post 0.63 EPS for the current fiscal year.

Institutional Trading of Trupanion

Hedge funds have recently made changes to their positions in the stock. Illinois Municipal Retirement Fund raised its stake in Trupanion by 2.3% during the first quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider’s stock valued at $456,000 after buying an additional 406 shares during the last quarter. Squarepoint Ops LLC grew its stake in shares of Trupanion by 0.7% in the second quarter. Squarepoint Ops LLC now owns 71,382 shares of the financial services provider’s stock worth $1,768,000 after acquiring an additional 482 shares during the last quarter. Arizona State Retirement System grew its stake in shares of Trupanion by 7.7% in the second quarter. Arizona State Retirement System now owns 9,587 shares of the financial services provider’s stock worth $237,000 after acquiring an additional 688 shares during the last quarter. Kelleher Financial Advisors purchased a new stake in shares of Trupanion in the second quarter worth $42,000. Finally, Parallel Advisors LLC grew its stake in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after acquiring an additional 1,722 shares during the last quarter.

Analyst Upgrades and Downgrades

Several brokerages have commented on TRUP. Piper Sandler lowered Trupanion from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $45.00 to $32.00 in a research report on Wednesday, August 26th. Weiss Ratings raised shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, September 29th. Cantor Fitzgerald decreased their price target on shares of Trupanion from $34.00 to $30.00 and set a “neutral” rating for the company in a research note on Wednesday, October 7th. Atlantic Securities set a $42.00 price target on shares of Trupanion in a research note on Wednesday, July 15th. Finally, Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 24th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $38.40.

Trupanion Company Profile

Trupanion, Inc is a pet insurance company that provides medical insurance for cats and dogs. Its coverage is designed to help pet owners manage eligible veterinary expenses, including treatment for accidents, illnesses and other covered medical conditions.

The company offers subscription-based insurance plans primarily through direct-to-consumer channels and partnerships with veterinary practices. Trupanion also provides tools intended to streamline claims processing and enable participating veterinarians to receive payments directly, reducing the need for pet owners to pay eligible costs upfront and seek reimbursement.

Founded in 2000, Trupanion is headquartered in Seattle, Washington.